The rapid increase in diabetes prevalence globally has contributed to large increases in health care expenditure on diabetic complications, posing a major health burden to countries worldwide. Asians are commonly observed to have poorer β-cell function and greater insulin resistance compared to the Caucasian population, which is attributed by their lower lean body mass and central obesity. This “double phenotype” as well as the rising prevalence of young onset diabetes in Asia has placed Asians with diabetes at high risk of cardiovascular and renal complications, with cancer emerging as an important cause of morbidity and mortality. The experience from Hong Kong had demonstrated that a multifaceted approach, involving team-based integrated care, information technological advances, and patient empowerment programs were able to reduce the incidence of diabetic complications, hospitalizations, and mortality. System change and public policies to enhance implementation of such programs may provide solutions to combat the burgeoning health problem of diabetes at a societal level.

Citations

Citations to this article as recorded by  

• Impact of Body Composition and Anemia on Accuracy of a Real-Time Continuous Glucose Monitor in Diabetes Patients on Continuous Ambulatory Peritoneal Dialysis
  James Ling, Jack K.C. Ng, Eric S.H. Lau, Andrea O.Y. Luk, Ronald C.W. Ma, Robert A. Vigersky, Philip K.T. Li, Juliana C.N. Chan, Cheuk Chun Szeto, Elaine Chow
  Diabetes Technology & Therapeutics.2024; 26(1): 70.     CrossRef
• Levels and correlates of risk factor control in diabetes mellitus –ELSA-Brasil
  Bruna Cristine Chwal, Rodrigo Citton Padilha dos Reis, Maria Inês Schmidt, Bruce B. Duncan, Sandhi Maria Barreto, Rosane Harter Griep
  Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
• Trends in risk factor control and treatment among patients with non‐alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory‐wide study
  Xinrong Zhang, Terry Cheuk‐Fung Yip, Yee‐Kit Tse, Vicki Wing‐Ki Hui, Guanlin Li, Huapeng Lin, Lilian Yan Liang, Jimmy Che‐To Lai, Mandy Sze‐Man Lai, Johnny T. K. Cheung, Henry Lik‐Yuen Chan, Stephen Lam Chan, Alice Pik‐Shan Kong, Grace Lai‐Hung Wong, Vinc
  Alimentary Pharmacology & Therapeutics.2023; 57(10): 1103.     CrossRef
• Team-Based Diabetes Care in Ontario and Hong Kong: a Comparative Review
  Calvin Ke, Emaad Mohammad, Juliana C. N. Chan, Alice P. S. Kong, Fok-Han Leung, Baiju R. Shah, Douglas Lee, Andrea O. Luk, Ronald C. W. Ma, Elaine Chow, Xiaolin Wei
  Current Diabetes Reports.2023; 23(7): 135.     CrossRef
• Team-Based Approach to Reduce Malignancies in People with Diabetes and Obesity
  Ziyue Zhu, Samuel Yeung Shan Wong, Joseph Jao Yiu Sung, Thomas Yuen Tung Lam
  Current Diabetes Reports.2023; 23(10): 253.     CrossRef
• Professor Juliana Chung Ngor Chan: Tireless Trailblazer for Diabetes Research, Care, and Education in Asia
  Ronald C.W. Ma, Wing Yee So, Andrea O.Y. Luk
  Diabetes Care.2022; 45(10): 2207.     CrossRef
• Predicting the Development of Myocardial Infarction in Middle-Aged Adults with Type 2 Diabetes: A Risk Model Generated from a Nationwide Population-Based Cohort Study in Korea
  Seung-Hwan Lee, Kyungdo Han, Hun-Sung Kim, Jae-Hyoung Cho, Kun-Ho Yoon, Mee Kyoung Kim
  Endocrinology and Metabolism.2020; 35(3): 636.     CrossRef
• From Hong Kong Diabetes Register to JADE Program to RAMP-DM for Data-Driven Actions
  Juliana C.N. Chan, Lee-Ling Lim, Andrea O.Y. Luk, Risa Ozaki, Alice P.S. Kong, Ronald C.W. Ma, Wing-Yee So, Su-Vui Lo
  Diabetes Care.2019; 42(11): 2022.     CrossRef
• Cholesterol levels and development of cardiovascular disease in Koreans with type 2 diabetes mellitus and without pre-existing cardiovascular disease
  Mee Kyoung Kim, Kyungdo Han, Han Na Joung, Ki-Hyun Baek, Ki-Ho Song, Hyuk-Sang Kwon
  Cardiovascular Diabetology.2019;[Epub]     CrossRef
• Effects of Variability in Blood Pressure, Glucose, and Cholesterol Concentrations, and Body Mass Index on End-Stage Renal Disease in the General Population of Korea
  Mee Kyoung Kim, Kyungdo Han, Hun-Sung Kim, Yong-Moon Park, Hyuk-Sang Kwon, Kun-Ho Yoon, Seung-Hwan Lee
  Journal of Clinical Medicine.2019; 8(5): 755.     CrossRef
• Efficacy and safety of fixed‐dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double‐blind, controlled, phase 3 trial
  Ji Cheol Bae, Kyung Wan Min, Yong Hyun Kim, Kyoung‐Ah Kim, Eun‐Gyoung Hong, Cheol‐Young Park, Song Han, Bong‐Soo Cha
  Diabetes, Obesity and Metabolism.2019; 21(1): 103.     CrossRef
• Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
  Yongin Cho, Myoung Soo Kim, Chung Mo Nam, Eun Seok Kang
  Scientific Reports.2019;[Epub]     CrossRef